
Oncology Nursing News
- December 2010
- Volume 4
- Issue 6
Bone Loss Drugs Increase Stroke Risk in Patients With Cancer
Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk
Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk for atrial fibrillation and stroke. According to a study published online in the Journal of Clinical Oncology, the absolute risk for these patients within 6 years of starting bisphosphonate treatment was approximately 8% for all supraventricular tachycardia events and 4% for stroke.
Articles in this issue
almost 15 years ago
Net Guides: Melanomaalmost 15 years ago
Net Guides: Bone Metastasesalmost 15 years ago
Yoga for Cancer Carealmost 15 years ago
FDA Updates: March 7, 2011almost 15 years ago
The Future of Nursingalmost 15 years ago
Net Guides: Liver Canceralmost 15 years ago
Net Guides: Carcinoma of Unknown Primary Orginalmost 15 years ago
Integrative Medicine and Cancer Treatmentalmost 15 years ago
Reimbursement for Nurse Navigation: It Can Be Donealmost 15 years ago
Tools to Help Patients Navigate Their Treatment Path


































